Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AntiGrippin
- Development stage
- Unknown
- Lead developer
- Natur Produkt International
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
AntiGrippin is an over-the-counter (OTC) pharmaceutical product primarily indicated as a remedy for cough, cold, and sore throat symptoms. It was originally part of the product portfolio of Natur Produkt International, JSC, a Russian specialty pharmaceutical company. In February 2013, Valeant Pharmaceuticals International acquired Natur Produkt International, thereby integrating AntiGrippin into its expanded OTC product offerings, particularly in the Russian market. As a typical cough, cold, and sore throat remedy, it is likely a combination of active ingredients designed to provide symptomatic relief.
- Brand names
- AntiGrippin
Beyond the preview
Go deeper on AntiGrippin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AntiGrippin.